123 related articles for article (PubMed ID: 29555502)
1. Ameliorating effect of TI-1-162, a hydroxyindenone derivative, against TNBS-induced rat colitis is mediated through suppression of RIP/ASK-1/MAPK signaling.
Gurung P; Banskota S; Katila N; Gautam J; Kadayat TM; Choi DY; Lee ES; Jeong TC; Kim JA
Eur J Pharmacol; 2018 May; 827():94-102. PubMed ID: 29555502
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-κB signaling pathways.
Park S; Regmi SC; Park SY; Lee EK; Chang JH; Ku SK; Kim DH; Kim JA
Eur J Pharmacol; 2014 Jul; 735():184-92. PubMed ID: 24769511
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats.
Park SY; Neupane GP; Lee SO; Lee JS; Kim MY; Kim SY; Park BC; Park YJ; Kim JA
Arch Pharm Res; 2014 Feb; 37(2):253-62. PubMed ID: 24166708
[TBL] [Abstract][Full Text] [Related]
4. 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction.
Park SY; Ku SK; Lee ES; Kim JA
Chem Biol Interact; 2012 Mar; 196(1-2):39-49. PubMed ID: 22410118
[TBL] [Abstract][Full Text] [Related]
5. Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease.
Kadayat TM; Banskota S; Gurung P; Bist G; Thapa Magar TB; Shrestha A; Kim JA; Lee ES
Eur J Med Chem; 2017 Sep; 137():575-597. PubMed ID: 28646757
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rd attenuates the inflammatory response via modulating p38 and JNK signaling pathways in rats with TNBS-induced relapsing colitis.
Yang XL; Guo TK; Wang YH; Huang YH; Liu X; Wang XX; Li W; Zhao X; Wang LP; Yan S; Wu D; Wu YJ
Int Immunopharmacol; 2012 Feb; 12(2):408-14. PubMed ID: 22227208
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Xu J; Zheng C; Huang Y; Liang Y
Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
[TBL] [Abstract][Full Text] [Related]
9. Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species.
Regmi SC; Park SY; Ku SK; Kim JA
Free Radic Biol Med; 2014 Apr; 69():377-89. PubMed ID: 24524998
[TBL] [Abstract][Full Text] [Related]
10. Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling.
Lee JS; Park SY; Thapa D; Choi MK; Chung IM; Park YJ; Yong CS; Choi HG; Kim JA
Exp Mol Med; 2010 Feb; 42(2):143-54. PubMed ID: 20054232
[TBL] [Abstract][Full Text] [Related]
11. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats.
Rosillo MA; Sánchez-Hidalgo M; Cárdeno A; Aparicio-Soto M; Sánchez-Fidalgo S; Villegas I; de la Lastra CA
Pharmacol Res; 2012 Sep; 66(3):235-42. PubMed ID: 22677088
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
Chen Y; Chen Y; Liu WL; Zhou TH; Cai JT; Du Q; Wang LJ; Wu JG; Si JM
J Gastroenterol Hepatol; 2009 May; 24(5):912-9. PubMed ID: 19220658
[TBL] [Abstract][Full Text] [Related]
13. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
14. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis.
Camacho-Barquero L; Villegas I; Sánchez-Calvo JM; Talero E; Sánchez-Fidalgo S; Motilva V; Alarcón de la Lastra C
Int Immunopharmacol; 2007 Mar; 7(3):333-42. PubMed ID: 17276891
[TBL] [Abstract][Full Text] [Related]
15. 2',4',6'-tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid-induced colitis and blocks tumor necrosis factor-alpha-induced intestinal epithelial inflammation via heme oxygenase 1-dependent and independent pathways.
Lee SH; Sohn DH; Jin XY; Kim SW; Choi SC; Seo GS
Biochem Pharmacol; 2007 Sep; 74(6):870-80. PubMed ID: 17678632
[TBL] [Abstract][Full Text] [Related]
16. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of protease-activated receptor 2 protects against experimental colitis.
Lohman RJ; Cotterell AJ; Suen J; Liu L; Do AT; Vesey DA; Fairlie DP
J Pharmacol Exp Ther; 2012 Feb; 340(2):256-65. PubMed ID: 22028393
[TBL] [Abstract][Full Text] [Related]
18. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-kappaB activation.
Kim KJ; Lee JS; Kwak MK; Choi HG; Yong CS; Kim JA; Lee YR; Lyoo WS; Park YJ
Eur J Pharmacol; 2009 Nov; 622(1-3):52-7. PubMed ID: 19765578
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
